Cite
HARVARD Citation
Schiff, M. et al. (2008). Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate. Annals of the rheumatic diseases. 67 (8), pp. 1096-1103. [Online].